Name

ClinicalStudyDataRequest.com (CSDR)

Legal name

ideaPoint

Website

https://clinicalstudydatarequest.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

ClinicalStudyDataRequest.com (CSDR) is a multi-sponsor clinical trial data sharing consortium, launched in 2014, that enables academic researchers to request anonymized patient-level data from pharmaceutical sponsors and academic funders through an Independent Review Panel-governed web portal built on ideaPoint (Anaqua) technology.

Ownership category

akta.pro rank

Product category

Clinical Trial Data Sharing Platform

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industry

Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)

Keywords

• Clinical trial data sharing
• Multi-sponsor data platform
• Patient-level data access
• Clinical research portal
• Pharmaceutical data sharing

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Infrastructure, Others

Revenue model

1. Platform Services to Sponsors: Pharmaceutical company sponsors (Astellas, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eisai, GSK, Lilly, Novartis, Roche, Sanofi, Takeda, UCB, ViiV Healthcare) and academic funders (Bill & Melinda Gates Foundation, Cancer Research UK, Medical Research Council, Wellcome Trust) join the consortium to list their clinical trial data. The platform is powered by ideaPoint (Anaqua company) with operational support from Wellcome Trust.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

ClinicalStudyDataRequest.com (CSDR) is a multi-sponsor clinical trial data sharing consortium and web portal that allows qualified researchers to request access to anonymized patient-level data from pharmaceutical company sponsors and academic funders. The platform, built on ideaPoint technology (Anaqua), supports a research workflow including proposal submission, Independent Review Panel evaluation, Data Sharing Agreement execution, and access to data within a secure workspace equipped with SAS, R, and Plink analytics tools. The service is provided free to researchers, with operational costs borne by sponsor members and Wellcome Trust.

Product overview

ClinicalStudyDataRequest.com (CSDR) is a multi-sponsor clinical trial data sharing consortium and web portal enabling researchers to request anonymized patient-level data from pharmaceutical companies and academic funders. The platform centers on the CSDR Portal as the main interface, supported by the Independent Review Panel for proposal evaluation and a Secure Data Access System with embedded analytics tools (SAS, R, Plink). Core workflow products include Research Proposal Submission and Enquiry Facility for requesting listed and unlisted studies. The platform is built on the ideaPoint technology platform by Anaqua and supports multi-sponsor data requests allowing researchers to combine data from multiple pharmaceutical sponsors and academic funders in a single submission.

Differentiator

Problem solved

Functional benefit

Products and services

• ClinicalStudyDataRequest.com Portal Multi-sponsor web-based portal that enables qualified researchers to browse 3,046+ clinical studies listed by 13 pharmaceutical sponsors and 4 academic funders, and request access to anonymized patient-level data through an Independent Review Panel process.
• Independent Review Panel (IRP) Independent panel of experts that reviews research proposals for scientific merit before granting data access, with Wellcome Trust providing secretariat support for the review process.
• Secure Data Access System Secure workspace providing access to anonymized patient-level data with controls preventing data export, including pre-installed analytics tools (SAS, R, Plink) for researchers to conduct analyses.
• Research Proposal Submission System Online system for researchers to submit proposals requesting access to clinical trial data, with checklist requirements including statistical analysis plan and publication plan.
• Enquiry Facility System for researchers to enquire about availability of data from clinical studies not yet listed on the site, including document-only access requests.
• Multi-Sponsor Data Request System Capability enabling researchers to combine data requests from multiple pharmaceutical company sponsors and academic funders in a single research proposal submission.

Quantifiable outcome

• Reduced average time from submission to data access from 200 days (2018) to 139 days (2019) to 5.5 months mean (2021)
• +3 more outcomes

Named customers25 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

19 partnerships are on record, tiered minor and core.

• Southampton Clinical Trials UnitminorStrategic or Co-development Partner · 1 July 2018First academic organization to list an academic-led clinical trial on CSDR in July 2018. Has since listed 7 trials total on the platform, including trials of non-drug treatments.
• Bill & Melinda Gates FoundationcoreStrategic or Co-development Partner · 23 April 2018One of four major academic funders that partnered with CSDR in April 2018 to expand access to patient-level clinical trial data. Gates Foundation encourages researchers they fund to share trial data through the platform.
• Cancer Research UKcoreStrategic or Co-development Partner · 23 April 2018Major academic funder partner in the CSDR consortium since April 2018. Supports listing of Cancer Research UK-funded clinical trials for data sharing on the platform.
• Medical Research Council (MRC)coreStrategic or Co-development Partner · 23 April 2018UK-based medical research funding body that joined CSDR consortium in April 2018 to enable MRC-funded researchers to share clinical trial data through the platform.
• ideaPoint (Anaqua)coreTechnology or Integration · 1 January 2014ideaPoint, an Anaqua company, provides the technology platform powering CSDR. Since its launch in 2008, ideaPoint has delivered software solutions to pharmaceutical, biotechnology, and medical device organizations for collaboration, licensing, and partnering. ideaPoint powers the secure request and evaluation process behind CSDR.
• Wellcome TrustcoreStrategic or Co-development Partner · 1 January 2014Wellcome Trust provides secretariat support to the Independent Review Panel and oversees the review process. Wellcome Trust is a member of the consortium and supports CSDR's goal of ensuring clinical trial data is shared independently and transparently.
• GSKcoreStrategic or Co-development Partner · 1 July 2013Founding pharmaceutical sponsor of CSDR. GSK lists studies from December 2000 to December 2022. GSK was among the first data sponsors when the platform launched in January 2014.
• RochecoreStrategic or Co-development Partner · 1 July 2013Founding pharmaceutical sponsor listing all Phase 2 and 3 clinical studies with first patient enrolled as of January 1999 onwards.
• SanoficoreStrategic or Co-development Partner · 1 July 2013Founding pharmaceutical sponsor committed to sharing clinical study data per PhRMA/EFPIA principles.
• ViiV HealthcarecoreStrategic or Co-development Partner · 1 July 2013Founding pharmaceutical sponsor specializing in HIV research. Listed studies from January 2014 to December 2022. New requests from 2023 directed to Vivli platform.
• Boehringer IngelheimcoreStrategic or Co-development Partner · 1 July 2013Founding pharmaceutical sponsor listing completed studies after primary endpoint completion date and regulatory review completion.
• AstellascoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor listing Phase 1-4 interventional clinical studies completed after January 2010 for approved products.
• NovartiscoreStrategic or Co-development Partner · 1 January 2013Major pharmaceutical sponsor sharing anonymized data via Vivli for multi-sponsor requests and via CSDR for Novartis-only requests. Shares data 18 months after trial completion or after regulatory approval.
• BayercoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor member of the CSDR consortium for responsible clinical trial data sharing.
• TakedacoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor listing Phase 1-4 interventional trials for products approved since January 2005 and terminated compounds since January 2014.
• UCBcoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor listing pivotal studies for certolizumab pegol, lacosamide, rotigotine and levetiracetam. Now redirecting requests to alternative platform.
• EisaicoreStrategic or Co-development Partner · 1 January 2013Japanese pharmaceutical company with 10,000 employees including 1,500 in research. Sponsor listing Phase 2, 3, and 4 interventional studies approved by EMA and FDA after January 2014.
• Daiichi SankyocoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor listing Phase 2, 3, and 4 interventional studies for products approved in US, EU, and/or Japan after January 2014.
• LillycoreStrategic or Co-development Partner · 1 January 2013Pharmaceutical sponsor listed through the Boehringer Ingelheim policy on clinical study data transparency.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Vivli: Vivli is the leading multi-sponsor clinical trial data sharing platform, explicitly cited in CSDR's own materials as a parallel initiative where some sponsors (ViiV, Novartis) now direct multi-sponsor requests. Operates the same core function: anonymized IPD sharing with independent review.
• Project Data Sphere: Project Data Sphere is a nonprofit oncology-focused data sharing platform offering access to historical, anonymized Phase III comparator-arm clinical trial data. Comparable to CSDR in providing researchers a portal-based IPD request workflow, though narrower in therapeutic scope.
• Yale Open Data Access (YODA) Project: YODA at Yale University is one of the longest-running clinical trial data sharing programs, mediating IPD requests from medical device and pharma sponsors through an independent review committee. Directly comparable to CSDR's model of sponsor-consortium data sharing with third-party governance.

Others

• Clinical Data Interchange Standards Consortium (CDISC): CDISC develops data standards for clinical research that underpin interoperability of trial data across sponsors and platforms. Comparable as an adjacent ecosystem enabler whose standards support platforms like CSDR in harmonizing data across multiple sponsor sources.
• Clinical Trials Transformation Initiative (CTTI): Public-private partnership hosted by Duke University that develops recommendations to improve clinical trial quality and efficiency. Comparable as a multi-stakeholder consortium advancing clinical trial practice and transparency, though CTTI focuses on policy/methods rather than operating a data access portal.
• TransCelerate Biopharma: Industry consortium of 20+ pharma companies focused on clinical trial innovation, including data sharing initiatives. Comparable to CSDR's consortium structure and member roster of major pharma sponsors, though TransCelerate's mission spans the broader clinical trial lifecycle rather than just data sharing.

Broad incumbents

• Medidata (Dassault Systèmes): Medidata offers end-to-end clinical trial technology including EDC, RTSM, and clinical data management. Comparable as the broader enterprise platform layer for clinical trial data that encompasses the niche IPD-sharing functionality CSDR provides to secondary researchers.
• IQVIA: IQVIA is the largest CRO/clinical services provider with a portfolio spanning clinical trial operations, real-world data, and analytics platforms. Comparable as the broad incumbent offering data management and analytics infrastructure that overlaps with CSDR's data curation and accessibility capabilities.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clinicalstudydatarequest-com

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClinicalStudyDataRequest.com (CSDR)